NMDA-mediated Ca2+ influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice

Journal of Neuroscience

Volumn 30, Issue 36, 2010, Pages 12128-12137

  Goussakov, Ivan ^a   Miller, Megan B ^a   Stutzmann, Grace E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PRESENILIN; RYANODINE RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; AMYLOID PRECURSOR PROTEIN; CADMIUM CHLORIDE; CAFFEINE; CENTRAL STIMULANT AGENT; HEPARIN; N METHYLASPARTIC ACID; PRESENILIN 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PSEN1 PROTEIN, HUMAN; TAU PROTEIN; TRANSGLUTAMINASE 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; GENE DISRUPTION; MOUSE; NONHUMAN; PATCH CLAMP; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOLYSIS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; DRUG INTERACTION; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; MEMBRANE POTENTIAL; METABOLISM; MUTATION; PATCH CLAMP TECHNIQUE; PATHOLOGY; PREFRONTAL CORTEX; PROCEDURES; PYRAMIDAL NERVE CELL; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CADMIUM CHLORIDE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENDOPLASMIC RETICULUM; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION REGULATION; HEPARIN; HUMANS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MUTATION; N-METHYLASPARTATE; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PRESENILIN-1; PYRAMIDAL CELLS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TAU PROTEINS; TRANSGLUTAMINASES; IN VITRO TECHNIQUES;

EID: 77956586233     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2474-10.2010     Document Type: Article

References (41)

1. Berridge MJ (2006) Calcium microdomains: organization and function. Cell Calcium 40:405-412.
2. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31:454-463.
3. Bouchard R, Pattarini R, Geiger JD (2003) Presence and functional significance of presynaptic ryanodine receptors. Prog Neurobiol 69:391-418. (Pubitemid 36869008)
4. Brennan AR, Dolinsky B, Vu MA, Stanley M, Yeckel MF, Arnsten AF (2008) Blockade of IP3-mediated SK channel signaling in the rat medial prefrontal cortex improves spatial working memory. Learn Mem 15:93-96.
5. Burns A, Jacoby R (2008) Dimebon in Alzheimer's disease: old drug for new indication. Lancet 372:179-180.
6. Chakroborty S, Goussakov I, Miller MB, Stutzmann GE (2009) Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci 29:9458-9470.
7. Cheung KH, Shineman D, Müller M, Cardenas C, Mei L, Yang J, Tomita T, Iwatsubo T, Lee VM, Foskett JK (2008) Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58:871-883. (Pubitemid 351842747)
8. Cheung KH, Mei L, Mak DO, Hayashi I, Iwatsubo T, Kang DE, Foskett JK (2010) Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Sci Signal 3:ra22.
9. Collin T, Marty A, Llano I (2005) Presynaptic calcium stores and synaptic transmission. Curr Opin Neurobiol 15:275-281.
10. Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in Alzheimer's disease. J Biol Chem 285:12463-12468.
11. Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 372:207-215.
12. Fitzpatrick JS, Hagenston AM, Hertle DN, Gipson KE, Bertetto-D'Angelo L, Yeckel MF (2009) IP3 receptor-dependent Ca2+ waves in pyramidal neuron dendrites propagate through hot spots and cold spots. J Physiol 587:1439-1459.
13. Harkany T, Hortobágyi T, Sasvári M, Kónya C, Penke B, Luiten PG, Nyakas C (1999) Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 23:963-1008. (Pubitemid 29468909)
14. Hertle DN, Yeckel MF (2007) Distribution of inositol-1,4,5-trisphosphate receptor isotypes and ryanodine receptor isotypes during maturation of the rat hippocampus. Neuroscience 150:625-638.
15. Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI (2004) Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 1017:130-136.
16. Jones VC, McKeown L, Verkhratsky A, Jones OT (2008) LV-pIN-KDEL: a novel lentiviral vector demonstrates the morphology, dynamics and continuity of the endoplasmic reticulum in live neurons. BMC Neurosci 9:10.
17. Keller DX, Franks KM, Bartol TM Jr, Sejnowski TJ (2008) Calmodulin activation by calcium transients in the postsynaptic density of dendritic spines. PLoS One 3:e2045.
18. Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O'Neill C (1999) Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience 92:499-513. (Pubitemid 29268039)
19. Korkotian E, Segal M (2007) Morphological constraints on calcium dependent glutamate receptor trafficking into individual dendritic spine. Cell Calcium 42:41-57.
20. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3:862-872. (Pubitemid 135706704)
21. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10:509-519.
22. Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H (2004) Structural basis of long-term potentiation in single dendritic spines. Nature 429:761-766.
23. Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, Bezprozvanny I (2007) Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest 117:1230-1239.
24. Nicolay NH, Hertle D, Boehmerle W, Heidrich FM, Yeckel M, Ehrlich BE (2007) Inositol 1,4,5 trisphosphate receptor and chromogranin B are concentrated in different regions of the hippocampus. J Neurosci Res 85:2026-2036. (Pubitemid 47051491)
25. O'Neill C, Cowburn RF, Bonkale WL, Ohm TG, Fastbom J, Carmody M, Kelliher M (2001) Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 177-194.
26. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
27. Sabatini BL, Svoboda K (2000) Analysis of calcium channels in single spines using optical fluctuation analysis. Nature 408:589-593.
28. Seeber S, Humeny A, Herkert M, Rau T, Eschenhagen T, Becker CM (2004) Formation of molecular complexes by N-methyl-d-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard. J Biol Chem 279:21062-21068.
29. Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106-113.
30. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875.
31. Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM (2005) Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94:1711-1718.
32. Spacek J, HarrisKM (1997) Three-dimensional organization of smooth endoplasmic reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature rat. J Neurosci 17:190-203.
33. Stutzmann GE (2007) The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"? Neuroscientist 13:546-559.
34. Stutzmann GE, Parker I (2005) Dynamic multiphoton imaging: a live view from cells to systems. Physiology 20:15-21.
35. 2+ signals and altered membrane excitability. J Neurosci 24:508-513.
36. 2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26:5180-5189.
37. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
38. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, De Strooper B, Yu G, Bezprozvanny I (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126:981-993.
39. Verkhratsky A (2005) Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 85:201-279.
40. Yamin G (2009) NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res 87:1729-1736.
41. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Südhof TC, Shen J (2009) Presenilins are essential for regulating neurotransmitter release. Nature 460:632-636.